SMRT
LIVE

Serial Number

79254733

Owner

Orthocell Limited

Attorney

Matthew J. Stark

Filing Date

Jan 31, 2019

Add to watchlist:

No watchlists yet
View on USPTO

SMRT Trademark

Serial Number: 79254733 • Registration: 6391648

SMRT is a trademark filed by Orthocell Limited on January 31, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Orthocell Limited (15 trademarks)

Building 191,

Entity Type: 99

Trademark Details

Filing Date

January 31, 2019

Registration Date

June 22, 2021

Published for Opposition

April 6, 2021

Goods & Services

Stem cells for medical purposes for regeneration of bone and soft tissue; medical preparations for use in connection with the regeneration of bone and soft tissue; guided tissue regeneration materials, namely, medical preparations for use in connection with the regeneration of bone and soft tissue; biological preparations for medical purposes, namely, for the regeneration of bone and soft tissue; tissue-regenerative medical preparations, namely, for use in connection with the regeneration of bone and soft tissue; medical preparations in the nature of tissues for medical use, namely, for use in connection with the regeneration of bone and soft tissue; materials for dental treatment, namely, dental preparations for use in connection with the regeneration of dental tissue; materials for making dental restorations, namely, dental preparations for use in connection with the regeneration of dental tissue; dental repair materials, namely, dental preparations for use in connection with the regeneration of dental tissue; dental restorative materials, namely, dental preparations for use in connection with the regeneration of dental tissue; surgical implants, namely, living tissues grown from stem cells for use in connection with the regeneration of bone and soft tissue; collagen for medical use; medical preparations in the nature of biodegradable implants for use in guided tissue regeneration, namely, for use in connection with the regeneration of bone and soft tissue; medical preparations in the nature of implant materials for use in guided tissue regeneration in surgery, namely, for use in connection with the regeneration of bone and soft tissue; medical preparations in the nature of implantable materials for use in guided tissue regeneration, namely, for use in connection with the regeneration of bone and soft tissue; medical preparations in the nature of implants for guided tissue regeneration, namely, for use in connection with the regeneration of bone and soft tissue; therapeutic agents for medical purposes, namely, for the regeneration of bone and soft tissue; therapeutic biological tissue cultures for medical purposes, namely, for the regeneration of bone and soft tissue; none of the aforementioned goods being or in relation to genomics, sequencing of genomes, transcriptomes or epigenomes, medical diagnostic assays and reagents for use in genetic sequencing and biochemical analysis

Advisory services relating to medical services; physical therapy; medical services; medical advisory services; medical care services; medical health assessment services; medical treatment services for the regeneration of bone and soft tissue; provision of medical information; provision of medical services for the regeneration of bone and soft tissue; physical therapy services; all of the foregoing related to regeneration of bone and soft tissues and biomechanical and cellular therapeutic techniques

Scientific and technological research services in the field of biomechanical and cellular therapeutic medical techniques and design services, namely, design of new tissue and bone regeneration products and techniques related to biomechanical and cellular therapeutic techniques

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 3, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 8, 2021 FICS
FINAL DISPOSITION PROCESSED
Oct 8, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 22, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 22, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Apr 12, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 6, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 6, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 17, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 17, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 17, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 4, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 4, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 4, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 4, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 4, 2021 CNEA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 25, 2020 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 5, 2020 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 26, 2020 OPNR
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jul 24, 2020 LIMN
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 15, 2020 RCCK
ASSIGNED TO LIE
Jun 29, 2020 ALIE
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Feb 18, 2020 LIMN
LIMITATION OF GOODS RECEIVED FROM IB
Feb 7, 2020 LIMG
LIMITATION OF GOODS RECEIVED FROM IB
Jan 31, 2020 LIMG
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 4, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 4, 2019 GNSL
SUSPENSION LETTER WRITTEN
Dec 4, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 1, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 1, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 1, 2019 TROA
REFUSAL PROCESSED BY IB
May 25, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 3, 2019 RFCS
REFUSAL PROCESSED BY MPU
May 3, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 18, 2019 RFCR
NON-FINAL ACTION WRITTEN
Apr 17, 2019 CNRT
ASSIGNED TO EXAMINER
Apr 10, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 30, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 26, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 21, 2019 REPR